Dr. Suzanne Bruhn
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Suzanne Bruhn
Dr. Suzanne Bruhn is recorded as CEO at Definium Therapeutics, Inc. (DFTX).
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
2022-01-01–2025-04-23
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Definium Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Roger Crystal CEO
- JR Rahn CEO
- Robert Barrow CEO
- Stephen Hurst CEO
- Carol A. Vallone Chairman
- Brandi L. Roberts CFO
- David Gryska CFO
- Roger Adsett COO, Board Member
- Carrie F. Liao Chief Accounting Officer
- Andreas Krebs Board Member
Recent activity
No call appearances or filed executive changes recorded yet.